Floatz logo

NADROPARIN

Bypass Complications

Rijnstate Hospitalother_biologicalPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

13 Active assets in the Bypass Complications cohort.

Asset / SponsorPhaseRating
AUTOLOGOUS CONDITIONED PLASMA
Star Spine and Sport
Phase 4BB
Velpatasvir
Alexandria University
Phase 4BB
Sofosbuvir
Alexandria University
Phase 4BB
NEPENTHE
Hopital Lariboisière
Phase 4BB
NEPENTHE
Tiva Group
Phase 4BB

View all 37 →

Same molecule, other indications

NADROPARIN is also rated in:

venous thromboembolismDormant
BBB
Indicative ·
75 / 100
View asset →
Esophageal and Gastric VaricesDormant
BB
Indicative ·
69 / 100
View asset →
Anticoagulant-induced BleedingDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →